REGISTERED NUMBER: 05899807 (England and Wales)

STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

FOR

FARMACY PLC

Page

Company Information

1

Strategic Report

2

Report of the Directors

3

Report of the Independent Auditors

5

Statement of Comprehensive Income

9

Balance Sheet

10

Statement of Changes in Equity

11

Cash Flow Statement

12

Notes to the Cash Flow Statement

13

Notes to the Financial Statements

14

DIRECTORS:

M F Young

E J A Wilson

SECRETARY:

E J A Wilson

REGISTERED OFFICE:

Farmacy Services Centre

Sleaford Road

Dorrington

Lincolnshire

LN4 3PU

REGISTERED NUMBER:

05899807 (England and Wales)

SENIOR STATUTORY AUDITOR:

Robert Booty ACA FCCA CTA

AUDITORS:

Wheelers

Chartered Accountants, Tax Consultants

& Statutory Auditors

27-29 Old Market

Wisbech

Cambridgeshire

PE13 1NE

BANKERS:

Barclays Bank PLC

The directors present their strategic report for the year ended 31 December 2025.

Farmacy plc is an agricultural advisory company, which provides consultancy and crop management services to arable farmers throughout mainland UK.

UK farming experienced another challenging spring during 2025, the dry March and April weather especially impacted Spring-sown crops. Following on from the weather affected cropping in 2024, this resulted in a difficult year for our clients. Throughout the year, Farmacy continued to provide support wherever possible and focused attention on helping farmers maximise the potential of their crops.

Our colleagues' unwavering dedication throughout this challenging time has allowed Farmacy to continue to deliver exceptional service to our clients. I am very grateful for their commitment.

Fees in the year under review increased by 5.2% to £8.0 million (2024: £7.6m). Gross profit decreased to 4.6% (2024: 4.9%). The business's profit before tax decreased to £149,663 (2024: £171,047).

During 2025 Farmacy continued to develop new ways to support our clients amidst changes in the agricultural sector. This included developments to the Omnia platform, further enhancing the functionality of our leading agronomic technology. Further investment demonstrates our commitment to the sector and our clients. In addition, through our Helix agronomic research and development programme, we consistently equip our agronomists with exceptional technical information to ensure they offer the highest quality advice to our clients.

We continue to invest in our most important resource, our people, both through the training and development of our existing colleagues and the recruitment of new team members.

Farmacy strives to provide a working environment in which our employees can flourish and realise their full potential and ambitions. We continue to plan for the long term, with ambitious recruitment and career development objectives that will enable future succession as well as business growth.

The directors are pleased with the company's performance during the year and with its financial position at the balance sheet date. They are confident that Farmacy will continue to enjoy a successful future.

ON BEHALF OF THE BOARD:

E J A Wilson - Secretary

26 June 2026

The directors present their report with the financial statements of the company for the year ended 31 December 2025.

PRINCIPAL ACTIVITY

The company specialises in the provision of professional agronomic and environmental services.

DIVIDENDS

No dividends will be distributed for the year ended 31 December 2025.

DIRECTORS

The directors shown below have held office during the whole of the period from 1 January 2025 to the date of this report.

M F Young

E J A Wilson

Other changes in directors holding office are as follows:

G D McKechnie - resigned 10 June 2025

DISCLOSURE IN THE STRATEGIC REPORT

In accordance with Section 414C(11) of the Companies Act 2006 other matters, normally included within this report, are set out in the Strategic Report.

STATEMENT OF DIRECTORS' RESPONSIBILITIES

The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-	select suitable accounting policies and then apply them consistently;

-	make judgements and accounting estimates that are reasonable and prudent;

-	state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements;

-	prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS

So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS

In accordance with Section 487(2) of the Companies Act 2006 the auditors, Wheelers, are deemed to have been re-appointed.

ON BEHALF OF THE BOARD:

E J A Wilson - Secretary

26 June 2026

Opinion

We have audited the financial statements of Farmacy plc (the 'company') for the year ended 31 December 2025 which comprise the Statement of Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

-	give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its profit for the year then ended;

-	have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

-	have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

-	the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and

-	the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

-	adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

-	the financial statements are not in agreement with the accounting records and returns; or

-	certain disclosures of directors' remuneration specified by law are not made; or

-	we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We obtained an understanding of the legal and regulatory frameworks that are applicable to the company and

determined that the most significant are:

- Those that relate to the reporting framework (United Kingdom Accounting Standards in conformity with the

Companies Act 2006 and FRS102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland").

- Relevant tax compliance regulations in the United Kingdom.

- In addition, we concluded that there are certain laws and regulations that may have an effect on the determination of the amounts and disclosures in the financial statements; and laws and regulations relating to health and safety, employee matters and the environment.

We understood how Farmacy plc is complying with those frameworks by making enquiries of management, those

responsible for legal and compliance procedures and the Company Secretary. We corroborated our enquiries through our review of Board minutes.

We assessed the susceptibility of the company's financial statements to material misstatement, including how fraud might occur, by discussion with management and our prior knowledge of the company's activities and controls. We have carried out procedures including a review of journal entries and a review of accounting estimates and judgements which were designed to provide reasonable assurance that the financial statements were free from fraud or error.

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those

leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Robert Booty ACA FCCA CTA (Senior Statutory Auditor)

for and on behalf of Wheelers

Chartered Accountants, Tax Consultants

& Statutory Auditors

27-29 Old Market

Wisbech

Cambridgeshire

PE13 1NE

26 June 2026

TURNOVER

3

8,037,396

7,632,916

Cost of sales

7,664,244

7,261,565

GROSS PROFIT

373,152

371,351

Administrative expenses

264,707

231,315

108,445

140,036

Other operating income

47,538

31,078

OPERATING PROFIT

5

155,983

171,114

Interest payable and similar expenses

6

6,320

67

PROFIT BEFORE TAXATION

149,663

171,047

Tax on profit

7

44,598

57,052

PROFIT FOR THE FINANCIAL YEAR

105,065

113,995

OTHER COMPREHENSIVE INCOME

-

-

TOTAL COMPREHENSIVE INCOME FOR THE YEAR

105,065

113,995

FIXED ASSETS

Intangible assets

8

15,336

30,672

Tangible assets

9

-

1,464

Investments

10

1,202

1,202

16,538

33,338

CURRENT ASSETS

Debtors

11

2,262,278

2,031,951

Cash at bank

57,056

58,688

2,319,334

2,090,639

CREDITORS

Amounts falling due within one year

12

618,461

511,631

NET CURRENT ASSETS

1,700,873

1,579,008

TOTAL ASSETS LESS CURRENT LIABILITIES

1,717,411

1,612,346

CAPITAL AND RESERVES

Called up share capital

13

50,000

50,000

Retained earnings

14

1,667,411

1,562,346

SHAREHOLDERS' FUNDS

1,717,411

1,612,346

The financial statements were approved by the Board of Directors and authorised for issue on 26 June 2026 and were signed on its behalf by:

E J A Wilson - Director

Called up

share

Retained

Total

capital

earnings

equity

£

£

£

Balance at 1 January 2024

50,000

1,448,351

1,498,351

Changes in equity

Total comprehensive income

-

113,995

113,995

Balance at 31 December 2024

50,000

1,562,346

1,612,346

Changes in equity

Total comprehensive income

-

105,065

105,065

Balance at 31 December 2025

50,000

1,667,411

1,717,411

Cash flows from operating activities

Cash generated from operations

1

74,103

137,911

Interest paid

(6,320

)

(67

)

Tax paid

(69,415

)

(119,965

)

Net cash from operating activities

(1,632

)

17,879

Cash flows from investing activities

Purchase of intangible fixed assets

-

(16,671

)

Net cash from investing activities

-

(16,671

)

(Decrease)/increase in cash and cash equivalents

(1,632

)

1,208

Cash and cash equivalents at beginning of year

2

58,688

57,480

Cash and cash equivalents at end of year

2

57,056

58,688

1.	RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

31.12.25

31.12.24

£

£

Profit before taxation

149,663

171,047

Depreciation and amortisation

16,800

44,663

Finance costs

6,320

67

172,783

215,777

Increase in trade and other debtors

(212,562

)

(330,157

)

Increase in trade and other creditors

113,882

252,291

Cash generated from operations

74,103

137,911

2.	CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 December 2025

31.12.25

1.1.25

£

£

Cash and cash equivalents

57,056

58,688

Year ended 31 December 2024

31.12.24

1.1.24

£

£

Cash and cash equivalents

58,688

57,480

3.	ANALYSIS OF CHANGES IN NET FUNDS

At 1.1.25

Cash flow

At 31.12.25

£

£

£

Net cash

Cash at bank

58,688

(1,632

)

57,056

58,688

(1,632

)

57,056

Total

58,688

(1,632

)

57,056

1.	STATUTORY INFORMATION

Farmacy plc is a public company, limited by shares, registered in England and Wales. The company's registered number and registered office can be found on the Company information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The directors believe that the company is well placed to manage its financial risks successfully and have reasonable expectation that it has adequate resources to continue in operational existence for the foreseeable future. Consequently, it continues to adopt the going concern basis of accounting in preparing the annual financial statements.

The company has taken exemption under section 400 of the Companies Act 2006 not to prepare consolidated financial statements.

These financial statements give information on Farmacy plc as an entity only. The results of the company and its subsidiaries are consolidated in the financial statements of the ultimate parent company, Hutchinsons Group Limited, in which intra group sales and profits are eliminated and all sales and profit figures relate to external transactions only.

In these financial statements, the company is considered to be a qualifying entity (for the purposes of this FRS) and has applied the exemptions available under FRS 102 in respect of the following disclosures:

- Reconciliation of the number of shares outstanding from beginning to end of the period;

- Key Management Personnel compensation

As the consolidated financial statements of Hutchinsons Group Limited include the equivalent disclosures, the company has also taken the exemptions under FRS102 available in respect of the following disclosures:

- The disclosures required by FRS102.11 Basic Financial Instruments and FRS102.12 Other Financial Instrument Issues in respect of financial instruments not falling within the fair value accounting rules of Paragraph 36(4) of Schedule 1.

Related party exemption

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Significant judgements and estimates

The preparation of financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported for assets and liabilities as at the balance sheet date and amounts reported for revenues and expenses during the year. However, the nature of estimation means that actual outcomes could differ from those estimates. The following judgements have had the most significant effect on amounts recognised in the financial statements:

Revenue and profit recognition

The estimation techniques used for revenue and profit recognition in respect of the recharges made from a fellow subsidiary company require assessment and judgements to be made on the profit element in respect of work done by Farmacy plc.

Turnover and income recognition

Turnover represents the invoiced value, net of value added tax, of services provided both directly to third parties and through other group companies. Income under annual contracts is accounted for on a straight line basis over the period of the agreement.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of businesses is being amortised evenly over its estimated useful life of five years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses. Such cost includes costs directly attributable to making the asset capable of operating as intended.

Provision for depreciation is made so as to write off the cost of tangible fixed assets on a straight line basis over the expected useful economic lives of the assets concerned. The principal annual rates used for this purpose, which are consistent with those of last year, are:-

%

Office equipment

20 - 40

All other assets

10 - 40

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost less any provision for impairment.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Comprehensive Income, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development

Expenditure on research and development is written off in the year in which it is incurred.

Pension costs and other post-retirement benefits

Contributions are made to a group pension scheme providing benefits based on final pensionable pay. Contributions to the scheme are charged to the profit and loss account based on the contributions paid in the year, which spread the cost of the pensions over the employees working lives with the company. The contributions are determined by a qualified actuary on the basis of a triennial valuation.

The company has been advised that it is not possible to analyse the assets and liabilities of this multi-employer scheme by individual companies. As a result of this the full disclosures required under FRS 102 are made in the accounts of H L Hutchinson Limited.

The company also operates defined contribution schemes. Contributions are charged to the profit and loss account as they become payable.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement. The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities, including trade and other debtors, trade and other creditors, cash and bank balances at the transaction price.

3.

TURNOVER

Turnover is attributable to the principal activities of the company and arises from continuing activities within the United Kingdom.

4.	EMPLOYEES AND DIRECTORS

31.12.25

31.12.24

£

£

Wages and salaries

4,525,039

4,301,988

Social security costs

679,497

560,746

Other pension costs

433,729

411,309

5,638,265

5,274,043

The average number of employees during the year was as follows:

31.12.25

31.12.24

Staff

69

72

Directors

1

1

70

73

For reasons of operational efficiency all staff are remunerated by a group company.

The costs and average number of employees engaged in the performance of duties for Farmacy plc are detailed above. All recharges are made on actual cost basis.

31.12.25

31.12.24

£

£

Directors' remuneration

133,450

135,432

5.	OPERATING PROFIT

The operating profit is stated after charging:

31.12.25

31.12.24

£

£

Depreciation - owned assets

1,464

2,945

Goodwill amortisation

15,336

41,718

Auditors' remuneration

9,400

8,410

6.

INTEREST PAYABLE AND SIMILAR EXPENSES

31.12.25

31.12.24

£

£

Other interest payable

6,320

67

7.

TAXATION

Analysis of the tax charge

The tax charge on the profit for the year was as follows:

31.12.25

31.12.24

£

£

Current tax:

UK corporation tax

44,598

57,052

Tax on profit

44,598

57,052

Reconciliation of total tax charge included in profit and loss

The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

31.12.25

31.12.24

£

£

Profit before tax

149,663

171,047

Profit multiplied by the standard rate of corporation tax in the UK of 25% (2024 - 25%)

37,416

42,762

Effects of:

Expenses not deductible for tax purposes

7,319

14,290

Over provision in prior years

(137

)

-

Total tax charge

44,598

57,052

Factors that may affect future tax charges

The company is not aware of any factors that may affect future tax charges other than the change in corporation tax rates.

8.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 January 2025

and 31 December 2025

1,174,312

AMORTISATION

At 1 January 2025

1,143,640

Amortisation for year

15,336

At 31 December 2025

1,158,976

NET BOOK VALUE

At 31 December 2025

15,336

At 31 December 2024

30,672

9.	TANGIBLE FIXED ASSETS

Plant and

Office

machinery

equipment

Totals

£

£

£

COST

At 1 January 2025

and 31 December 2025

17,766

14,260

32,026

DEPRECIATION

At 1 January 2025

16,302

14,260

30,562

Charge for year

1,464

-

1,464

At 31 December 2025

17,766

14,260

32,026

NET BOOK VALUE

At 31 December 2025

-

-

-

At 31 December 2024

1,464

-

1,464

10.	FIXED ASSET INVESTMENTS

Shares in

group

undertakings

£

COST

At 1 January 2025

and 31 December 2025

1,573,072

PROVISIONS

At 1 January 2025

and 31 December 2025

1,571,870

NET BOOK VALUE

At 31 December 2025

1,202

At 31 December 2024

1,202

The following subsidiaries are all dormant:-

Name

Country of incorporation

Description of shares held

Holding

Agrivice Limited

England and Wales

Ordinary £1 shares

100%

Allium & Brassica Agronomy Limited

England and Wales

Ordinary £1 shares

100%

The Allium & Brassica Centre Limited

England and Wales

Ordinary £1 shares

100%

The registered office for the dormant subsidiary companies are as follows:-

Name

Registered office

Agrivice Limited

Farmacy Services Centre, Sleaford Road, Dorrington, Lincoln, LN4 3PU

Allium & Brassica Agronomy Limited

Farmacy Services Centre, Sleaford Road, Dorrington, Lincoln, LN4 3PU

The Allium & Brassica Centre Limited

Farmacy Services Centre, Sleaford Road, Dorrington, Lincoln, LN4 3PU

11.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.25

31.12.24

£

£

Trade debtors

742,802

983,940

Amounts owed by group undertakings

1,411,069

765,950

Amounts owed by participating interests

22,027

199,736

Corporation tax

17,765

-

Prepayments and accrued income

68,615

82,325

2,262,278

2,031,951

Amounts owed by group undertakings and participating interests are interest free and repayable on demand.

12.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.25

31.12.24

£

£

Trade creditors

41,765

69,213

Amounts owed to group undertakings

1,202

1,202

Corporation tax

-

7,052

Other creditors

565,694

423,801

Accruals and deferred income

9,800

10,363

618,461

511,631

13.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.12.25

31.12.24

value:

£

£

50,000

Ordinary

£1

50,000

50,000

Ordinary shares rank pari passu in respect to voting, capital and dividend rights (including winding up rights). All shares are not redeemable.